

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of clathrin-mediated endocytosis (GO:2000369) | 8.16013846 |
| 2 | positive regulation of antigen processing and presentation (GO:0002579) | 7.62740021 |
| 3 | regulation of acrosome reaction (GO:0060046) | 6.47588018 |
| 4 | regulation of antigen processing and presentation (GO:0002577) | 6.19133292 |
| 5 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 5.78612982 |
| 6 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.46373005 |
| 7 | complement activation, alternative pathway (GO:0006957) | 4.65138568 |
| 8 | GPI anchor biosynthetic process (GO:0006506) | 4.44582111 |
| 9 | plasma membrane fusion (GO:0045026) | 4.22483556 |
| 10 | GPI anchor metabolic process (GO:0006505) | 4.09013918 |
| 11 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.78066058 |
| 12 | brown fat cell differentiation (GO:0050873) | 3.68951624 |
| 13 | regulation of Cdc42 GTPase activity (GO:0043088) | 3.60546629 |
| 14 | response to misfolded protein (GO:0051788) | 3.44717373 |
| 15 | valine metabolic process (GO:0006573) | 3.38389082 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.35357375 |
| 17 | negative regulation of metanephros development (GO:0072217) | 3.32529645 |
| 18 | positive regulation of glomerulus development (GO:0090193) | 3.30928050 |
| 19 | macroautophagy (GO:0016236) | 3.25134816 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 3.22962867 |
| 21 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.22499120 |
| 22 | positive regulation of response to oxidative stress (GO:1902884) | 3.22499120 |
| 23 | eye photoreceptor cell differentiation (GO:0001754) | 3.19787063 |
| 24 | photoreceptor cell differentiation (GO:0046530) | 3.19787063 |
| 25 | respiratory burst (GO:0045730) | 3.18189022 |
| 26 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.08912224 |
| 27 | white fat cell differentiation (GO:0050872) | 2.95196051 |
| 28 | low-density lipoprotein particle clearance (GO:0034383) | 2.89340959 |
| 29 | cell differentiation involved in metanephros development (GO:0072202) | 2.87274085 |
| 30 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.86269204 |
| 31 | metanephric nephron tubule development (GO:0072234) | 2.83513706 |
| 32 | metanephric tubule development (GO:0072170) | 2.83513706 |
| 33 | axon ensheathment in central nervous system (GO:0032291) | 2.79187922 |
| 34 | central nervous system myelination (GO:0022010) | 2.79187922 |
| 35 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.77528903 |
| 36 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.77259518 |
| 37 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.77259518 |
| 38 | negative regulation of protein autophosphorylation (GO:0031953) | 2.77052618 |
| 39 | cellular anion homeostasis (GO:0030002) | 2.76131600 |
| 40 | L-serine transport (GO:0015825) | 2.75038781 |
| 41 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.74260241 |
| 42 | triglyceride catabolic process (GO:0019433) | 2.73579259 |
| 43 | regulation of lipoprotein metabolic process (GO:0050746) | 2.73445522 |
| 44 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.72875297 |
| 45 | glycolipid biosynthetic process (GO:0009247) | 2.72441758 |
| 46 | cellular sodium ion homeostasis (GO:0006883) | 2.70473446 |
| 47 | negative regulation of endocytosis (GO:0045806) | 2.65766957 |
| 48 | cellular response to epinephrine stimulus (GO:0071872) | 2.65384821 |
| 49 | linoleic acid metabolic process (GO:0043651) | 2.64944354 |
| 50 | L-amino acid import (GO:0043092) | 2.63496036 |
| 51 | metanephric nephron epithelium development (GO:0072243) | 2.58547771 |
| 52 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.57926637 |
| 53 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.57407211 |
| 54 | cell differentiation involved in kidney development (GO:0061005) | 2.57148223 |
| 55 | glycerolipid catabolic process (GO:0046503) | 2.55603128 |
| 56 | mannose metabolic process (GO:0006013) | 2.48937354 |
| 57 | import into cell (GO:0098657) | 2.48486102 |
| 58 | nucleobase catabolic process (GO:0046113) | 2.47926549 |
| 59 | adaptation of signaling pathway (GO:0023058) | 2.45333348 |
| 60 | glycerophospholipid catabolic process (GO:0046475) | 2.44137276 |
| 61 | neutral lipid catabolic process (GO:0046461) | 2.44077697 |
| 62 | acylglycerol catabolic process (GO:0046464) | 2.44077697 |
| 63 | metanephric epithelium development (GO:0072207) | 2.43402021 |
| 64 | serine transport (GO:0032329) | 2.42416094 |
| 65 | response to nitrosative stress (GO:0051409) | 2.42400677 |
| 66 | nephron tubule development (GO:0072080) | 2.41409791 |
| 67 | negative regulation of lipase activity (GO:0060192) | 2.39690880 |
| 68 | positive regulation of sterol transport (GO:0032373) | 2.39217923 |
| 69 | positive regulation of cholesterol transport (GO:0032376) | 2.39217923 |
| 70 | * negative regulation of endopeptidase activity (GO:0010951) | 2.39020923 |
| 71 | polyol transport (GO:0015791) | 2.37870147 |
| 72 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.34191291 |
| 73 | alpha-linolenic acid metabolic process (GO:0036109) | 2.34081667 |
| 74 | amino acid import (GO:0043090) | 2.33368519 |
| 75 | trivalent inorganic anion homeostasis (GO:0072506) | 2.33142532 |
| 76 | phosphate ion homeostasis (GO:0055062) | 2.33142532 |
| 77 | cytolysis (GO:0019835) | 2.32872379 |
| 78 | positive regulation of digestive system process (GO:0060456) | 2.32826777 |
| 79 | * negative regulation of peptidase activity (GO:0010466) | 2.31828735 |
| 80 | regulation of feeding behavior (GO:0060259) | 2.30885718 |
| 81 | nerve growth factor signaling pathway (GO:0038180) | 2.30287293 |
| 82 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.30239590 |
| 83 | mesonephros development (GO:0001823) | 2.27184151 |
| 84 | cranial nerve structural organization (GO:0021604) | 2.26776310 |
| 85 | cyclooxygenase pathway (GO:0019371) | 2.26243367 |
| 86 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.25985517 |
| 87 | regulation of sequestering of triglyceride (GO:0010889) | 2.25641097 |
| 88 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.24698560 |
| 89 | renal tubule development (GO:0061326) | 2.24469022 |
| 90 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.23904012 |
| 91 | response to epinephrine (GO:0071871) | 2.22278219 |
| 92 | regulation of complement activation (GO:0030449) | 2.20898815 |
| 93 | cellular response to monoamine stimulus (GO:0071868) | 2.19635527 |
| 94 | cellular response to catecholamine stimulus (GO:0071870) | 2.19635527 |
| 95 | positive regulation of metanephros development (GO:0072216) | 2.18180941 |
| 96 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 14.0216842 |
| 97 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 13.9260949 |
| 98 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 13.9260949 |
| 99 | antigen processing and presentation via MHC class Ib (GO:0002475) | 13.0607573 |
| 100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 11.6257545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 5.92544010 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.59996648 |
| 3 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.86663835 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.52981741 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.42452364 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.29901134 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.24621611 |
| 8 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.23859995 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16348658 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.14150909 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.14150909 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.13596836 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.11675319 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.07684516 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05333149 |
| 16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.02608134 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.01039692 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.98475468 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.93086617 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.90017348 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89025874 |
| 22 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.88724978 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.85450838 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82390971 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.76433627 |
| 26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.69202138 |
| 27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.63477698 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.56779273 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55975338 |
| 30 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.51412242 |
| 31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50311144 |
| 32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50165925 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.47094352 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.44864118 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41083829 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40757954 |
| 37 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.36130872 |
| 38 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.35259438 |
| 39 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33989997 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.33771610 |
| 41 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33099778 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31284417 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.28773669 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27045922 |
| 45 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.26138623 |
| 46 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25255611 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25184668 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.24414320 |
| 49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22726342 |
| 50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21397959 |
| 51 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20903618 |
| 52 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.20072187 |
| 53 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.19564675 |
| 54 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.19234090 |
| 55 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.18903014 |
| 56 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16021319 |
| 57 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15886691 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14921454 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14215610 |
| 60 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.13530789 |
| 61 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.13124633 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12868430 |
| 63 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08251290 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08122199 |
| 65 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.05481558 |
| 66 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.03024840 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02860039 |
| 68 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02725068 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01663426 |
| 70 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00915386 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99408524 |
| 72 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98731034 |
| 73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98205093 |
| 74 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97982516 |
| 75 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97834280 |
| 76 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97151054 |
| 77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96686382 |
| 78 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.96473961 |
| 79 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95620093 |
| 80 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.93101968 |
| 81 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93044488 |
| 82 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92064007 |
| 83 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92058615 |
| 84 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91269209 |
| 85 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90549346 |
| 86 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.88198600 |
| 87 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.87234116 |
| 88 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87216363 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.86401224 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.85847435 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85542716 |
| 92 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84930643 |
| 93 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84930432 |
| 94 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.84927900 |
| 95 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.84775737 |
| 96 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84763749 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83744437 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83589621 |
| 99 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.82890113 |
| 100 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.81672010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.51380114 |
| 2 | MP0005670_abnormal_white_adipose | 3.70110917 |
| 3 | MP0002876_abnormal_thyroid_physiology | 2.98898597 |
| 4 | MP0003690_abnormal_glial_cell | 2.72442146 |
| 5 | MP0001501_abnormal_sleep_pattern | 2.57777411 |
| 6 | MP0006292_abnormal_olfactory_placode | 2.53951423 |
| 7 | MP0001486_abnormal_startle_reflex | 2.16603763 |
| 8 | MP0003195_calcinosis | 2.07271719 |
| 9 | MP0005666_abnormal_adipose_tissue | 2.05193990 |
| 10 | MP0003950_abnormal_plasma_membrane | 1.85568447 |
| 11 | MP0005375_adipose_tissue_phenotype | 1.74753167 |
| 12 | MP0010386_abnormal_urinary_bladder | 1.72446411 |
| 13 | MP0002254_reproductive_system_inflammat | 1.69620570 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 1.68582446 |
| 15 | MP0004185_abnormal_adipocyte_glucose | 1.66876636 |
| 16 | MP0008004_abnormal_stomach_pH | 1.65082485 |
| 17 | MP0000566_synostosis | 1.62038048 |
| 18 | MP0000920_abnormal_myelination | 1.59605144 |
| 19 | MP0003880_abnormal_central_pattern | 1.56126280 |
| 20 | MP0002272_abnormal_nervous_system | 1.51746253 |
| 21 | MP0003938_abnormal_ear_development | 1.49776470 |
| 22 | MP0005171_absent_coat_pigmentation | 1.49369955 |
| 23 | MP0004270_analgesia | 1.48200075 |
| 24 | MP0004130_abnormal_muscle_cell | 1.48048058 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.47053414 |
| 26 | MP0004742_abnormal_vestibular_system | 1.45437542 |
| 27 | MP0003878_abnormal_ear_physiology | 1.41730185 |
| 28 | MP0005377_hearing/vestibular/ear_phenot | 1.41730185 |
| 29 | MP0004043_abnormal_pH_regulation | 1.41403547 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.41174137 |
| 31 | MP0003635_abnormal_synaptic_transmissio | 1.36481394 |
| 32 | MP0002064_seizures | 1.36384942 |
| 33 | MP0009745_abnormal_behavioral_response | 1.35083179 |
| 34 | MP0002102_abnormal_ear_morphology | 1.34744562 |
| 35 | MP0002736_abnormal_nociception_after | 1.34336253 |
| 36 | MP0001485_abnormal_pinna_reflex | 1.33672874 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.32421186 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.31555498 |
| 39 | MP0001968_abnormal_touch/_nociception | 1.27703303 |
| 40 | MP0002249_abnormal_larynx_morphology | 1.26453719 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 1.24681105 |
| 42 | MP0005195_abnormal_posterior_eye | 1.22633946 |
| 43 | MP0000026_abnormal_inner_ear | 1.22383241 |
| 44 | MP0010329_abnormal_lipoprotein_level | 1.22244336 |
| 45 | MP0000003_abnormal_adipose_tissue | 1.20384031 |
| 46 | MP0004019_abnormal_vitamin_homeostasis | 1.19087178 |
| 47 | MP0004134_abnormal_chest_morphology | 1.17914897 |
| 48 | MP0003879_abnormal_hair_cell | 1.15878186 |
| 49 | MP0002063_abnormal_learning/memory/cond | 1.15787901 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.14237167 |
| 51 | MP0004859_abnormal_synaptic_plasticity | 1.13802556 |
| 52 | MP0004885_abnormal_endolymph | 1.13455216 |
| 53 | MP0002229_neurodegeneration | 1.12664740 |
| 54 | MP0008995_early_reproductive_senescence | 1.11446767 |
| 55 | MP0001970_abnormal_pain_threshold | 1.11385949 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.11253334 |
| 57 | MP0005275_abnormal_skin_tensile | 1.11001069 |
| 58 | MP0002733_abnormal_thermal_nociception | 1.10215294 |
| 59 | MP0001963_abnormal_hearing_physiology | 1.09843980 |
| 60 | MP0005423_abnormal_somatic_nervous | 1.08936035 |
| 61 | MP0001440_abnormal_grooming_behavior | 1.08866148 |
| 62 | MP0004272_abnormal_basement_membrane | 1.08481199 |
| 63 | MP0003724_increased_susceptibility_to | 1.06568978 |
| 64 | MP0005334_abnormal_fat_pad | 1.06236887 |
| 65 | MP0002971_abnormal_brown_adipose | 1.05200253 |
| 66 | MP0001177_atelectasis | 1.04567181 |
| 67 | MP0002734_abnormal_mechanical_nocicepti | 1.04336894 |
| 68 | MP0000681_abnormal_thyroid_gland | 1.04004930 |
| 69 | MP0003634_abnormal_glial_cell | 1.03313088 |
| 70 | MP0002118_abnormal_lipid_homeostasis | 1.03068631 |
| 71 | MP0009115_abnormal_fat_cell | 1.02898537 |
| 72 | MP0003828_pulmonary_edema | 1.02875133 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 1.02793272 |
| 74 | MP0004858_abnormal_nervous_system | 1.01585412 |
| 75 | MP0005409_darkened_coat_color | 1.00515574 |
| 76 | MP0002557_abnormal_social/conspecific_i | 1.00322269 |
| 77 | MP0005164_abnormal_response_to | 0.99625109 |
| 78 | MP0005535_abnormal_body_temperature | 0.99335011 |
| 79 | MP0009046_muscle_twitch | 0.98920442 |
| 80 | MP0002067_abnormal_sensory_capabilities | 0.98496716 |
| 81 | MP0005248_abnormal_Harderian_gland | 0.97483477 |
| 82 | MP0009379_abnormal_foot_pigmentation | 0.96148714 |
| 83 | MP0009763_increased_sensitivity_to | 0.95290724 |
| 84 | MP0005253_abnormal_eye_physiology | 0.95128347 |
| 85 | MP0005595_abnormal_vascular_smooth | 0.94770106 |
| 86 | MP0002752_abnormal_somatic_nervous | 0.93005394 |
| 87 | MP0000778_abnormal_nervous_system | 0.91326059 |
| 88 | MP0001764_abnormal_homeostasis | 0.91034549 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.90986895 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.89240271 |
| 91 | MP0005379_endocrine/exocrine_gland_phen | 0.87050333 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.86755753 |
| 93 | MP0003959_abnormal_lean_body | 0.86294941 |
| 94 | MP0003075_altered_response_to | 0.86280860 |
| 95 | MP0002882_abnormal_neuron_morphology | 0.81062275 |
| 96 | MP0006276_abnormal_autonomic_nervous | 0.80536256 |
| 97 | MP0003186_abnormal_redox_activity | 0.79966875 |
| 98 | MP0001727_abnormal_embryo_implantation | 0.79466269 |
| 99 | MP0005410_abnormal_fertilization | 0.78431793 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.78364484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Choroideremia (HP:0001139) | 8.92924100 |
| 2 | Abnormality of the fovea (HP:0000493) | 8.08475016 |
| 3 | Abnormal rod and cone electroretinograms (HP:0008323) | 7.98406799 |
| 4 | Bony spicule pigmentary retinopathy (HP:0007737) | 7.03762086 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.77369422 |
| 6 | Complement deficiency (HP:0004431) | 5.46469388 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.56182259 |
| 8 | Stridor (HP:0010307) | 4.32525144 |
| 9 | Neurofibrillary tangles (HP:0002185) | 4.31649074 |
| 10 | Hypopigmentation of the fundus (HP:0007894) | 4.15860086 |
| 11 | Abnormality of complement system (HP:0005339) | 3.90774277 |
| 12 | Action tremor (HP:0002345) | 3.76383318 |
| 13 | Clumsiness (HP:0002312) | 3.64399202 |
| 14 | 11 pairs of ribs (HP:0000878) | 3.63066705 |
| 15 | Hyperphosphatemia (HP:0002905) | 3.53285818 |
| 16 | Nonprogressive disorder (HP:0003680) | 3.52364480 |
| 17 | Vascular calcification (HP:0004934) | 3.44811421 |
| 18 | Cerebral inclusion bodies (HP:0100314) | 3.39300482 |
| 19 | Diaphragmatic weakness (HP:0009113) | 3.34661677 |
| 20 | Intention tremor (HP:0002080) | 3.30749338 |
| 21 | Potter facies (HP:0002009) | 3.26426632 |
| 22 | Facial shape deformation (HP:0011334) | 3.26426632 |
| 23 | Facial diplegia (HP:0001349) | 3.13408204 |
| 24 | Cardiovascular calcification (HP:0011915) | 3.09723782 |
| 25 | Hand muscle atrophy (HP:0009130) | 3.09690485 |
| 26 | Hypophosphatemic rickets (HP:0004912) | 3.07863256 |
| 27 | Abnormality of macular pigmentation (HP:0008002) | 3.05644432 |
| 28 | Thyroid-stimulating hormone excess (HP:0002925) | 3.04629105 |
| 29 | Oligomenorrhea (HP:0000876) | 2.89506440 |
| 30 | Decreased central vision (HP:0007663) | 2.83081831 |
| 31 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.75342353 |
| 32 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.75342353 |
| 33 | Hemiplegia (HP:0002301) | 2.65095441 |
| 34 | Osteomalacia (HP:0002749) | 2.62697160 |
| 35 | Infantile muscular hypotonia (HP:0008947) | 2.57573843 |
| 36 | Hyperglycinuria (HP:0003108) | 2.56938690 |
| 37 | Aplasia involving bones of the extremities (HP:0009825) | 2.55352683 |
| 38 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.55352683 |
| 39 | Aplasia of the phalanges of the hand (HP:0009802) | 2.55352683 |
| 40 | Metaphyseal cupping (HP:0003021) | 2.54381143 |
| 41 | Ankle clonus (HP:0011448) | 2.53672524 |
| 42 | Dyschromatopsia (HP:0007641) | 2.49028152 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.46481428 |
| 44 | Distal upper limb amyotrophy (HP:0007149) | 2.42795883 |
| 45 | Upper limb amyotrophy (HP:0009129) | 2.42795883 |
| 46 | Missing ribs (HP:0000921) | 2.39361703 |
| 47 | Duplicated collecting system (HP:0000081) | 2.32937987 |
| 48 | Pigmentary retinal degeneration (HP:0001146) | 2.29466045 |
| 49 | Supranuclear gaze palsy (HP:0000605) | 2.29370237 |
| 50 | Hyperglycinemia (HP:0002154) | 2.28228945 |
| 51 | Hypoventilation (HP:0002791) | 2.20412339 |
| 52 | Agitation (HP:0000713) | 2.19875672 |
| 53 | Abnormality of macrophages (HP:0004311) | 2.17722259 |
| 54 | Hypertriglyceridemia (HP:0002155) | 2.16151478 |
| 55 | Parakeratosis (HP:0001036) | 2.16068861 |
| 56 | Aplasia of the musculature (HP:0100854) | 2.15136418 |
| 57 | Abnormality of glycine metabolism (HP:0010895) | 2.14848794 |
| 58 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14848794 |
| 59 | Focal motor seizures (HP:0011153) | 2.14049989 |
| 60 | Acanthosis nigricans (HP:0000956) | 2.04842281 |
| 61 | Polar cataract (HP:0010696) | 2.04173433 |
| 62 | Central scotoma (HP:0000603) | 2.01169250 |
| 63 | Abnormality of the renal collecting system (HP:0004742) | 1.99245252 |
| 64 | Tubulointerstitial fibrosis (HP:0005576) | 1.93920375 |
| 65 | Myocardial infarction (HP:0001658) | 1.93459577 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 1.93361942 |
| 67 | Abnormality of molar morphology (HP:0011070) | 1.91747713 |
| 68 | Abnormality of molar (HP:0011077) | 1.91747713 |
| 69 | Abnormality of the calcaneus (HP:0008364) | 1.91622746 |
| 70 | Prolonged neonatal jaundice (HP:0006579) | 1.91272281 |
| 71 | Progressive inability to walk (HP:0002505) | 1.90714404 |
| 72 | Hypoplasia of the iris (HP:0007676) | 1.90498676 |
| 73 | Subcapsular cataract (HP:0000523) | 1.90183440 |
| 74 | Mutism (HP:0002300) | 1.89265110 |
| 75 | Hyperthyroidism (HP:0000836) | 1.88710277 |
| 76 | Myopathic facies (HP:0002058) | 1.88491840 |
| 77 | Restlessness (HP:0000711) | 1.85184748 |
| 78 | Nasolacrimal duct obstruction (HP:0000579) | 1.81941087 |
| 79 | Abnormality of the dental root (HP:0006486) | 1.76187459 |
| 80 | Taurodontia (HP:0000679) | 1.76187459 |
| 81 | Abnormality of permanent molar morphology (HP:0011071) | 1.76187459 |
| 82 | Congenital stationary night blindness (HP:0007642) | 1.76176585 |
| 83 | Epileptic encephalopathy (HP:0200134) | 1.75750526 |
| 84 | Long nose (HP:0003189) | 1.75454849 |
| 85 | Abnormality of the lumbar spine (HP:0100712) | 1.74976750 |
| 86 | Atelectasis (HP:0100750) | 1.70896415 |
| 87 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.63597233 |
| 88 | Bulbar palsy (HP:0001283) | 1.62290089 |
| 89 | Macular degeneration (HP:0000608) | 1.61444986 |
| 90 | Widely spaced teeth (HP:0000687) | 1.60682944 |
| 91 | Cone-rod dystrophy (HP:0000548) | 1.60008136 |
| 92 | Abnormality of the corticospinal tract (HP:0002492) | 1.59418679 |
| 93 | Abnormality of renal resorption (HP:0011038) | 1.59184390 |
| 94 | White forelock (HP:0002211) | 1.57780540 |
| 95 | Myokymia (HP:0002411) | 1.55210830 |
| 96 | Loss of speech (HP:0002371) | 1.54861536 |
| 97 | Abnormality of the dental pulp (HP:0006479) | 1.54380487 |
| 98 | Focal segmental glomerulosclerosis (HP:0000097) | 1.53989801 |
| 99 | Progressive visual loss (HP:0000529) | 1.53877835 |
| 100 | Thin ribs (HP:0000883) | 1.52844424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 3.34702908 |
| 2 | CDK19 | 3.29553797 |
| 3 | INSRR | 2.95347669 |
| 4 | TAOK3 | 2.77700494 |
| 5 | PRPF4B | 2.43117030 |
| 6 | WNK4 | 2.37849617 |
| 7 | MYLK | 2.31133163 |
| 8 | EPHB2 | 2.23098707 |
| 9 | SIK1 | 2.12857624 |
| 10 | MAP2K7 | 2.04386373 |
| 11 | RIPK4 | 2.02240756 |
| 12 | STK39 | 1.70744857 |
| 13 | IRAK2 | 1.69328000 |
| 14 | PKN1 | 1.63327374 |
| 15 | NTRK3 | 1.61103322 |
| 16 | SIK3 | 1.55900235 |
| 17 | WNK1 | 1.53189698 |
| 18 | LMTK2 | 1.51348957 |
| 19 | SIK2 | 1.49201769 |
| 20 | EPHB1 | 1.46504758 |
| 21 | BLK | 1.44150274 |
| 22 | BCR | 1.43370657 |
| 23 | TNIK | 1.40932887 |
| 24 | IRAK1 | 1.40373787 |
| 25 | BMPR1B | 1.37925042 |
| 26 | EPHA4 | 1.31001868 |
| 27 | MKNK2 | 1.25568671 |
| 28 | IRAK3 | 1.24776757 |
| 29 | OXSR1 | 1.23533921 |
| 30 | MST4 | 1.21910316 |
| 31 | MARK1 | 1.21564274 |
| 32 | PBK | 1.20100556 |
| 33 | GRK7 | 1.19229648 |
| 34 | PHKG1 | 1.16299619 |
| 35 | PHKG2 | 1.16299619 |
| 36 | MAP2K4 | 1.14616685 |
| 37 | MAP3K14 | 1.12444836 |
| 38 | BMX | 1.12019452 |
| 39 | MAP3K4 | 1.11525523 |
| 40 | MAPK13 | 1.06827714 |
| 41 | NTRK2 | 1.06563487 |
| 42 | BMPR2 | 1.02932409 |
| 43 | GRK5 | 1.02293827 |
| 44 | GRK1 | 0.99936861 |
| 45 | MST1R | 0.97820261 |
| 46 | FGR | 0.95124547 |
| 47 | DAPK2 | 0.93131877 |
| 48 | TIE1 | 0.91081457 |
| 49 | FER | 0.89215613 |
| 50 | LATS1 | 0.88632348 |
| 51 | PRKCG | 0.87056194 |
| 52 | NEK6 | 0.84775379 |
| 53 | PINK1 | 0.83398714 |
| 54 | AKT3 | 0.83097012 |
| 55 | DDR2 | 0.82303939 |
| 56 | PRKCE | 0.81954802 |
| 57 | ADRBK2 | 0.79927949 |
| 58 | PAK3 | 0.77607334 |
| 59 | YES1 | 0.76544884 |
| 60 | FRK | 0.76530906 |
| 61 | ERBB4 | 0.75275863 |
| 62 | STK16 | 0.75125419 |
| 63 | CDK5 | 0.72255929 |
| 64 | SGK1 | 0.71240246 |
| 65 | MAPK12 | 0.69037979 |
| 66 | CAMK1D | 0.68812199 |
| 67 | MAP3K12 | 0.67535333 |
| 68 | PRKCH | 0.66872268 |
| 69 | PTK2B | 0.66681354 |
| 70 | TNK2 | 0.66554501 |
| 71 | FYN | 0.66190212 |
| 72 | CAMK1G | 0.63605477 |
| 73 | MET | 0.63545030 |
| 74 | CAMK2A | 0.62134490 |
| 75 | FGFR2 | 0.60742888 |
| 76 | STK38L | 0.60430528 |
| 77 | CAMK2B | 0.59597472 |
| 78 | PRKCZ | 0.58106830 |
| 79 | SRC | 0.57914142 |
| 80 | SGK223 | 0.57450150 |
| 81 | SGK494 | 0.57450150 |
| 82 | INSR | 0.56702711 |
| 83 | PRKACA | 0.51390840 |
| 84 | MAP3K13 | 0.50237356 |
| 85 | ADRBK1 | 0.48226665 |
| 86 | EGFR | 0.47259135 |
| 87 | FES | 0.43626781 |
| 88 | MUSK | 0.43575115 |
| 89 | PRKG1 | 0.43440509 |
| 90 | PRKACG | 0.42854909 |
| 91 | IRAK4 | 0.42329308 |
| 92 | LATS2 | 0.39395123 |
| 93 | TGFBR2 | 0.38473715 |
| 94 | MAPK7 | 0.37366569 |
| 95 | MAP2K1 | 0.36958903 |
| 96 | DYRK2 | 0.35962978 |
| 97 | ERBB3 | 0.35389588 |
| 98 | PAK6 | 0.35143374 |
| 99 | CAMK2G | 0.34128309 |
| 100 | ERBB2 | 0.33830433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.68288553 |
| 2 | ABC transporters_Homo sapiens_hsa02010 | 2.81723227 |
| 3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.55588379 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.44244496 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.41920467 |
| 6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.36705750 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.29566244 |
| 8 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.99535234 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.94674028 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89333681 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 1.85360887 |
| 12 | Phototransduction_Homo sapiens_hsa04744 | 1.77590496 |
| 13 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.76311100 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.70556082 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.65348582 |
| 16 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60281272 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.55145205 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48776954 |
| 19 | Prion diseases_Homo sapiens_hsa05020 | 1.47988477 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46478206 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.45949223 |
| 22 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.42251665 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.39303341 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.38762706 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29859067 |
| 26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.28604109 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.28488383 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.27262733 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.26456389 |
| 30 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.25307485 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.24504778 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.24495270 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.19744643 |
| 34 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.17695051 |
| 35 | Morphine addiction_Homo sapiens_hsa05032 | 1.17556741 |
| 36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.16777656 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10467439 |
| 38 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.10043667 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04585917 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03154178 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03151801 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.00131048 |
| 43 | Taste transduction_Homo sapiens_hsa04742 | 0.99830267 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99506122 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.93673181 |
| 46 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.93274537 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92991613 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92677212 |
| 49 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.89321892 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88471470 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87948158 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.87171015 |
| 53 | Circadian entrainment_Homo sapiens_hsa04713 | 0.86512932 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85209833 |
| 55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85048410 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.83523560 |
| 57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81862907 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.81472317 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79409409 |
| 60 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78676579 |
| 61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78583043 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76761940 |
| 63 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.74650348 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74199316 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72310867 |
| 66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71658283 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70890614 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69302030 |
| 69 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69247030 |
| 70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67662737 |
| 71 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.63451209 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.63422295 |
| 73 | Axon guidance_Homo sapiens_hsa04360 | 0.63370249 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62977572 |
| 75 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62079142 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60668900 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59392148 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59124278 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.59006303 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57884482 |
| 81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.56647375 |
| 82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56444577 |
| 83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52718389 |
| 84 | Long-term depression_Homo sapiens_hsa04730 | 0.50019908 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47676237 |
| 86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47368574 |
| 87 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45855114 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45609033 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44122068 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.41513362 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39209660 |
| 92 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39025240 |
| 93 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.38780474 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38077741 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37674784 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37300942 |
| 97 | Insulin secretion_Homo sapiens_hsa04911 | 0.36237269 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34767725 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32357786 |
| 100 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.31958809 |

